Cargando…

Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population.

Data on myelodysplastic syndromes (MDS) are seldom collected by cancer registries and unbiased findings from population-based studies remain rare. We report detailed information on MDS in a well-defined French population in the period 1980-1990. The crude incidence rate was 3.2 per 100000 per year a...

Descripción completa

Detalles Bibliográficos
Autores principales: Maynadié, M., Verret, C., Moskovtchenko, P., Mugneret, F., Petrella, T., Caillot, D., Carli, P. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074591/
https://www.ncbi.nlm.nih.gov/pubmed/8688338
_version_ 1782137999565258752
author Maynadié, M.
Verret, C.
Moskovtchenko, P.
Mugneret, F.
Petrella, T.
Caillot, D.
Carli, P. M.
author_facet Maynadié, M.
Verret, C.
Moskovtchenko, P.
Mugneret, F.
Petrella, T.
Caillot, D.
Carli, P. M.
author_sort Maynadié, M.
collection PubMed
description Data on myelodysplastic syndromes (MDS) are seldom collected by cancer registries and unbiased findings from population-based studies remain rare. We report detailed information on MDS in a well-defined French population in the period 1980-1990. The crude incidence rate was 3.2 per 100000 per year and no significant change in incidence was noted in the study period. The sex ratio was 1.9 and the male predominance was present in all age groups. We observed a rise in incidence after 60 years of age but no significant change in incidence of MDS as a whole was observed over the period studied. Refractory anaemia with excess of blasts (RAEB) was the most frequent subtype. Overall 5 year transformation rate of MDS was 31% (+/- 4%) but it was 100% in RAEB in transformation. The observed 5 year survival rate was 23% +/- 3% and the corresponding corrected rate was 33%. The prognosis of RAEB in transformation was worse than the prognosis of other subtypes (P < 0.01). Discrepancies with epidemiological data from other European countries are discussed.
format Text
id pubmed-2074591
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20745912009-09-10 Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population. Maynadié, M. Verret, C. Moskovtchenko, P. Mugneret, F. Petrella, T. Caillot, D. Carli, P. M. Br J Cancer Research Article Data on myelodysplastic syndromes (MDS) are seldom collected by cancer registries and unbiased findings from population-based studies remain rare. We report detailed information on MDS in a well-defined French population in the period 1980-1990. The crude incidence rate was 3.2 per 100000 per year and no significant change in incidence was noted in the study period. The sex ratio was 1.9 and the male predominance was present in all age groups. We observed a rise in incidence after 60 years of age but no significant change in incidence of MDS as a whole was observed over the period studied. Refractory anaemia with excess of blasts (RAEB) was the most frequent subtype. Overall 5 year transformation rate of MDS was 31% (+/- 4%) but it was 100% in RAEB in transformation. The observed 5 year survival rate was 23% +/- 3% and the corresponding corrected rate was 33%. The prognosis of RAEB in transformation was worse than the prognosis of other subtypes (P < 0.01). Discrepancies with epidemiological data from other European countries are discussed. Nature Publishing Group 1996-07 /pmc/articles/PMC2074591/ /pubmed/8688338 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Maynadié, M.
Verret, C.
Moskovtchenko, P.
Mugneret, F.
Petrella, T.
Caillot, D.
Carli, P. M.
Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population.
title Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population.
title_full Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population.
title_fullStr Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population.
title_full_unstemmed Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population.
title_short Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population.
title_sort epidemiological characteristics of myelodysplastic syndrome in a well-defined french population.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074591/
https://www.ncbi.nlm.nih.gov/pubmed/8688338
work_keys_str_mv AT maynadiem epidemiologicalcharacteristicsofmyelodysplasticsyndromeinawelldefinedfrenchpopulation
AT verretc epidemiologicalcharacteristicsofmyelodysplasticsyndromeinawelldefinedfrenchpopulation
AT moskovtchenkop epidemiologicalcharacteristicsofmyelodysplasticsyndromeinawelldefinedfrenchpopulation
AT mugneretf epidemiologicalcharacteristicsofmyelodysplasticsyndromeinawelldefinedfrenchpopulation
AT petrellat epidemiologicalcharacteristicsofmyelodysplasticsyndromeinawelldefinedfrenchpopulation
AT caillotd epidemiologicalcharacteristicsofmyelodysplasticsyndromeinawelldefinedfrenchpopulation
AT carlipm epidemiologicalcharacteristicsofmyelodysplasticsyndromeinawelldefinedfrenchpopulation